Brawn Biotech Limited (BOM:530207)

Brawn Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	1.87	2.81	1.99	3.97	4.39	2.25
Cash & Short-Term Investments	1.87	2.81	1.99	3.97	4.39	2.25
Cash Growth	-1.11%	40.70%	-49.80%	-9.46%	95.36%	-43.31%
Accounts Receivable	70.67	35.48	34.13	38.83	53.15	28.1
Other Receivables	-	0.11	0.14	0.92	0.9	9.27
Receivables	70.76	35.72	34.47	39.96	54.21	37.49
Inventory	68.26	100.62	104.67	60.17	47.91	47.24
Prepaid Expenses	-	1.6	1.84	2.25	2.57	3.25
Other Current Assets	32.99	30.45	32.03	25.05	24.92	31.64
Total Current Assets	173.89	171.2	175	131.4	133.99	121.87
Property, Plant & Equipment	3.05	3.65	4.6	3.33	3.72	3.86
Long-Term Accounts Receivable	-	19.19	20.14	6.59	5.99	5.88
Long-Term Deferred Tax Assets	14.54	14.54	5.15	4.57	1.59	6.24
Other Long-Term Assets	-	-	-	0	-	-
Total Assets	191.48	208.57	204.89	145.89	145.3	137.85

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	140.19	144.09	82.38	56.75	64.69	40.52
Accrued Expenses	-	3.65	3.56	4.3	4.69	4.93
Current Income Taxes Payable	-	0.25	0.26	0.25	1.51	7.22
Other Current Liabilities	5.97	3.72	7.07	3.78	9.58	10.55
Total Current Liabilities	146.16	151.7	93.27	65.08	80.47	63.21
Pension & Post-Retirement Benefits	-	0.49	0.8	1.03	0.83	0.64
Other Long-Term Liabilities	-0	12.98	77.2	29.13	0.91	1.79
Total Liabilities	146.16	165.18	171.27	95.24	82.21	65.64

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	30	30	30	30	30	30
Additional Paid-In Capital	-	15.2	15.2	15.2	15.2	15.2
Retained Earnings	-	-1.96	-11.73	5.3	17.74	26.85
Comprehensive Income & Other	15.32	0.15	0.15	0.15	0.15	0.15
Shareholders' Equity	45.32	43.39	33.62	50.65	63.09	72.2
Total Liabilities & Equity	191.48	208.57	204.89	145.89	145.3	137.85

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash (Debt)	1.87	2.81	1.99	3.97	4.39	2.25
Net Cash Growth	-1.11%	40.70%	-49.80%	-9.46%	95.36%	-43.31%
Net Cash Per Share	0.61	0.94	0.66	1.32	1.46	0.75
Filing Date Shares Outstanding	2.53	3	3	3	3	3
Total Common Shares Outstanding	2.53	3	3	3	3	3
Working Capital	27.73	19.5	81.74	66.32	53.53	58.66
Book Value Per Share	17.95	14.46	11.21	16.88	21.03	24.07
Tangible Book Value	45.32	43.39	33.62	50.65	63.09	72.2
Tangible Book Value Per Share	17.95	14.46	11.21	16.88	21.03	24.07
Machinery	-	10.5	10.24	7.83	7.71	6.75

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error